CCP
GSK icon

Carmel Capital Partners’s GSK GSK Stock Holding History

Carmel Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26
Closed -$928 – 373
2023
Q3 		$928 Buy
26
+3
+13% +$106 ﹤0.01% 676
2023
Q2 		$805 Sell
23
-56
-71% -$2.01K ﹤0.01% 399
2023
Q1 		$2.8K Buy
+79
New +$2.76K ﹤0.01% 392

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carmel Capital Partners's GSK Position: Q4 2023 in Review

Carmel Capital Partners sold out of GSK (GSK) in Q4 2023, closing a stake of 26 shares — an estimated $928 sold.

Carmel Capital Partners first reported a position in GSK in Q1 2023 and held it in 3 quarters. The position peaked at $2.8K in Q1 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Carmel Capital Partners reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 26 GSK shares in Q4 2023, an estimated $928.
  • Carmel Capital Partners first reported a position in GSK in Q1 2023 and held it in 3 quarters.
  • Carmel Capital Partners's GSK position peaked at $2.8K in Q1 2023.
  • 895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.